This is incredibly risky: No quality control: You have no idea whats actually in the vial
For most people its indirect: appetite drops, total calories fall, protein slips, fluids/electrolytes drop, and nausea or constipation reduces intake even more
That said, tirzepatide hasnt been studied in pregnant people, so researchers dont know how these side effects might influence a fetus
Dispense the diluent slowly along the inner wall of the vial never aim at the powder bed
You cannot dose the components independently in a pre-mixed blend, which is the main trade-off versus buying them separately
Keywords: GLP1 receptor agonists, diabetes mellitus, malnutrition, sarcopenia, sarcopenic obesity Von der Blutzuckerkontrolle zur Gewichtsreduktion Potenzial der GLP-1-RA Neue Einsatzgebiete von GLP-1-Rezeptoragonisten Glucagon-like Peptide-1-Rezeptoragonisten (GLP-1-RA) sind bei Patient/-innen mit Diabetes mellitus Typ 2 (T2DM) bereits ein etablierter Bestandteil der Therapie, insbesondere wenn gleichzeitig eine Gewichtsreduktion angestrebt wird (1)